Topcon
7732
TEMONA
3985
Forside
2330
Okamoto Glass
7746
Delta-Fly Pharma
4598
(FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -1.30%1.88B | -4.65%458.69M | 1.10%453.86M | -1.91%491.5M | 0.50%473.62M | 2.90%1.9B | 1.95%481.07M | 4.42%448.91M | 1.65%501.09M | 3.80%471.24M |
Cost of revenue | 0.76%1.35B | -2.25%334.63M | 1.35%328.68M | 0.19%344.39M | 3.90%344.34M | 2.87%1.34B | 4.08%342.34M | 3.22%324.3M | 2.91%343.73M | 1.29%331.4M |
Gross profit | -6.23%525.64M | -10.57%124.06M | 0.47%125.19M | -6.51%147.11M | -7.55%129.28M | 2.96%560.54M | -2.96%138.73M | 7.68%124.61M | -1.00%157.36M | 10.27%139.84M |
Operating expense | -0.70%502.49M | -7.56%132.8M | 6.18%119.15M | 0.49%121.94M | -0.17%128.6M | -1.65%506.06M | 10.81%143.67M | -9.35%112.22M | -2.70%121.35M | -5.54%128.82M |
Operating profit | -57.51%23.15M | -77.01%-8.74M | -51.25%6.04M | -30.10%25.18M | -93.83%680K | 82.16%54.49M | -137.08%-4.94M | 253.27%12.39M | 5.19%36.02M | 215.22%11.02M |
Net non-operating interest income (expenses) | 15.69%-2M | 19.64%-405K | 9.60%-480K | 4.79%-576K | 26.40%-538K | 7.13%-2.37M | 52.32%-504K | 0.56%-531K | -9.80%-605K | -77.86%-731K |
Non-operating interest income | 0.00%6K | --1K | 0.00%3K | --0 | 0.00%2K | 20.00%6K | --0 | -70.00%3K | --1K | 0.00%2K |
Non-operating interest expense | -12.37%1.76M | -1.22%406K | -4.54%421K | -5.85%483K | -30.16%447K | -8.28%2.01M | -57.05%411K | -2.22%441K | 12.01%513K | 100.00%640K |
Total other finance cost | -33.33%248K | --0 | -33.33%62K | 0.00%93K | 0.00%93K | 0.00%372K | 0.00%93K | 0.00%93K | 0.00%93K | 0.00%93K |
Net investment income | 50.30%1.51M | -8.71%388K | 84.63%805K | 101.17%5K | -45.34%311K | -42.23%1M | -28.45%425K | -52.56%436K | -315.15%-426K | 2,007.41%569K |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 0 | -1.51M | ||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | 72.04%-3.53M | 41.15%-3.53M | 0 | 0 | 0 | -592.26%-12.61M | -156.73%-5.99M | -3,325.85%-9.48M | 118.10%118K | 215.52%2.75M |
Less:Other special charges | ---- | ---- | ---- | ---- | ---- | -13.96%2.75M | ---- | ---- | ---- | ---- |
Less:Write off | -64.24%3.53M | 8.89%3.53M | --0 | --0 | --0 | 814.94%9.86M | 4,160.53%3.24M | 3,325.85%9.48M | 59.45%-118K | -215.52%-2.75M |
Other non-operating income (expenses) | 29.11%4.11M | 1,385.71%360K | 2.65%194K | -12.54%265K | 21.03%3.29M | -53.27%3.18M | -101.50%-28K | -62.20%189K | -74.23%303K | -16.97%2.72M |
Income before tax | -44.89%23.25M | 4.96%-11.93M | 118.89%6.56M | -29.76%24.87M | -77.06%3.75M | 23.74%42.18M | -201.34%-12.55M | 143.40%3M | 2.90%35.41M | 381.47%16.33M |
Income tax | -41.61%10.61M | -62.82%-4.77M | 35.69%4.62M | -79.91%2.49M | 55.59%8.27M | 5.64%18.18M | -147.18%-2.93M | 233.37%3.41M | 134.46%12.38M | 13.25%5.32M |
Net income | -47.37%12.63M | 25.60%-7.16M | 570.80%1.94M | -2.80%22.38M | -141.12%-4.53M | 42.18%24M | -255.77%-9.62M | 94.81%-411K | -20.95%23.02M | 204.90%11.01M |
Net income continuous operations | -47.37%12.63M | 25.61%-7.16M | 570.80%1.94M | -2.80%22.38M | -141.11%-4.53M | 42.18%24M | -255.80%-9.62M | 94.81%-411K | -20.95%23.02M | 204.91%11.01M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | -47.37%12.63M | 25.60%-7.16M | 570.80%1.94M | -2.80%22.38M | -141.12%-4.53M | 42.18%24M | -255.77%-9.62M | 94.81%-411K | -20.95%23.02M | 204.90%11.01M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -47.37%12.63M | 25.60%-7.16M | 570.80%1.94M | -2.80%22.38M | -141.12%-4.53M | 42.18%24M | -255.77%-9.62M | 94.81%-411K | -20.95%23.02M | 204.90%11.01M |
Gross dividend payment | ||||||||||
Basic earnings per share | -47.37%1.1 | 26.19%-0.62 | 666.67%0.17 | -3.00%1.94 | -140.63%-0.39 | 42.18%2.09 | -255.56%-0.84 | 95.65%-0.03 | -20.95%2 | 205.49%0.96 |
Diluted earnings per share | -47.37%1.1 | 26.19%-0.62 | 570.80%0.1684 | -3.00%1.94 | -140.63%-0.39 | 42.18%2.09 | -256.33%-0.84 | 94.82%-0.0358 | -20.95%2 | 205.49%0.96 |
Dividend per share | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |